Azulfidine and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azulfidine (sulfasalazine) and Nasonex (mometasone furoate monohydrate). Common drug interactions include pericardial effusion among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Azulfidine and Nasonex. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Azulfidine?

Azulfidine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 7,997 Azulfidine users. Check the latest studies of Azulfidine.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.



On Jul, 15, 2026

29 people who take Azulfidine and Nasonex together, and have interactions are studied.

Azulfidine and Nasonex drug interactions.

What are the common drug interactions of Azulfidine and Nasonex, by gender? *:

female:

  1. Pericardial effusion (fluid around the heart)
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)
  4. Renal failure (kidney dysfunction)
  5. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Tricuspid valve incompetence (inefficient heart valve)
  8. Unresponsive to stimuli
  9. Ventricular fibrillation (abnormally irregular heart rhythm)
  10. Aphonia (inability to produce voice)

male:

  1. Asthenia (weakness)
  2. Headache (pain in head)
  3. Fatigue (feeling of tiredness)
  4. Joint swelling
  5. Local swelling (swelling at the site of some application of substance or injury)
  6. Muscular weakness (muscle weakness)
  7. Nausea (feeling of having an urge to vomit)
  8. Synovial cyst (cyst of joint filled with synovial fluid)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Thirst

What are the common drug interactions of Azulfidine and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Adrenal adenoma (benign tumour of the glandular type (adenoma) in the adrenal gland)
  2. Anxiety
  3. Atelectasis (partial or complete collapse of the lung)
  4. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
  5. Cardiac arrest
  6. Cardiogenic shock (inadequate circulation of blood)
  7. Cardiomyopathy (weakening of the heart muscle)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Colitis (inflammation of colon)
  10. Congestive cardiomyopathy (weakening of heart muscle)

40-49:

  1. Asthenia (weakness)
  2. Headache (pain in head)
  3. Thirst
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Blood pressure increased
  6. Heart rate increased
  7. Chest discomfort
  8. Dry mouth
  9. Dysgeusia (disorder of the sense of taste)
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Sinusitis (inflammation of sinus)

60+:

  1. Eye pain
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Left ventricular failure (left ventricle fails to contract forcefully)
  4. Anaemia (lack of blood)
  5. Aphonia (inability to produce voice)
  6. Cough
  7. Dry eye (lack of adequate tears)
  8. Dry mouth
  9. Dry skin
  10. Ear infection

What are the existing conditions these people have? *

  1. Muscle Spasms (muscle contraction): 10 people, 34.48%
  2. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 9 people, 31.03%
  3. Stress And Anxiety: 9 people, 31.03%
  4. Pain: 9 people, 31.03%
  5. Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 31.03%
  6. Diarrhea: 9 people, 31.03%
  7. Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 9 people, 31.03%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 31.03%
  9. High Blood Pressure: 4 people, 13.79%
  10. Sinus Congestion (blockage of sinus): 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Azulfidine and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azulfidine and Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azulfidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azulfidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfasalazine and mometasone furoate monohydrate (the active ingredients of Azulfidine and Nasonex, respectively), and Azulfidine and Nasonex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: